PACB Historical Earnings image   This PACB historical earnings page last updated 8/5/2022
PACB Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/3/20220.04B
Q1 20225/4/20220.03B
Q4 20212/15/20220.04B
Q3 202111/2/20210.03B
Q2 20218/3/20210.03B
Q1 20214/29/20210.03B
Q4 20202/10/20210.03B
Q3 202011/2/20200.02B
Q2 20208/3/20200.02B
Q1 20205/6/20200.02B
Q4 20192/6/20200.03B
Q3 201911/7/20190.02B
Q2 20198/6/20190.02B
Q1 20195/3/20190.02B
Q4 20182/11/201919.53M
Q3 201811/1/201818.16M
Q2 20188/2/201821.58M
Q1 20185/2/201819.36M
Q4 20172/1/201824.93M
Q3 201711/2/201723.55M
Q2 20178/2/201720.07M
Q1 20174/26/201724.91M
Q4 20162/2/201725.72M
Q3 201611/2/201625.12M
Q2 20168/4/201620.75M
Q1 20164/21/201619.13M
Q4 20152/3/201636.28M
Q3 201510/22/201513.92M
Q2 20158/5/201524.94M
Q1 20155/5/201517.60M
Q4 20142/3/201516.90M
Q3 201410/23/201420.60M
Q2 20147/24/201411.40M
Q1 20144/30/201411.60M
Q4 20132/4/20149.13M
Q3 201310/22/20137.40M
Q2 20138/1/20136.05M
Q1 20134/23/20135.58M
Q4 20122/5/20135.88M
Q3 201210/25/20120.00B
Q2 20127/26/20127.29M
PACB Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20228/3/2022-0.340
Q1 20225/4/2022-0.370
Q4 20212/15/2022-0.300
Q3 202111/2/2021-0.230
Q2 20218/3/2021-0.210
Q1 20214/29/2021-0.450
Q4 20202/10/20210.370
Q3 202011/2/2020-0.140
Q2 20208/3/2020-0.150
Q1 20205/6/20200.010
Q4 20192/6/20200.000
Q3 201911/7/2019-0.190
Q2 20198/6/2019-0.160
Q1 20195/3/2019-0.200
Q4 20182/11/2019-0.21
Q3 201811/1/2018-0.19
Q2 20188/2/2018-0.17
Q1 20185/2/2018-0.2
Q4 20172/1/2018-0.18
Q3 201711/2/2017-0.19
Q2 20178/2/2017-0.26
Q1 20174/26/2017-0.24
Q4 20162/2/2017-0.21
Q3 201611/2/2016-0.19
Q2 20168/4/2016-0.21
Q1 20164/21/2016-0.23
Q4 20152/3/2016-0.02
Q3 201510/22/2015-0.26
Q2 20158/5/2015-0.14
Q1 20155/5/2015-0.27
Q4 20142/3/2015-0.26
Q3 201410/23/2014-0.13
Q2 20147/24/2014-0.27
Q1 20144/30/2014-0.28
Q4 20132/4/2014-0.26
Q3 201310/22/2013-0.31
Q2 20138/1/2013-0.33
Q1 20134/23/2013-0.37
Q4 20122/5/2013-0.39
Q3 201210/25/2012-0.410
Q2 20127/26/2012-0.4
Quotes delayed 20 minutes

Email EnvelopeFree PACB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Pacific Biosciences (PACB) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PAHC Historical Earnings
PALI Historical Earnings
PASG Historical Earnings
PAVM Historical Earnings
PBH Historical Earnings
PBLA Historical Earnings
PBYI Historical Earnings
PCRX Historical Earnings
PCSA Historical Earnings
PCVX Historical Earnings
What was the record high PACB historical earnings result?
In terms of earnings or revenue, what is the best PACB historical earnings result that Pacific Biosciences has ever posted, and when?

✔️Accepted answer: Within our data set, the highest PACB historical earnings result was set in Q4 2020, when Pacific Biosciences posted results of 0.370/share. The most successful revenue quarter within our data set was Q4 2015 when Pacific Biosciences reported revenue of 36.28M.

What was the lowest Pacific Biosciences historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest PACB has reported, and when?

✔️Accepted answer: Within our data set, the lowest PACB historical earnings result was set in Q1 2021, when Pacific Biosciences posted results of -0.450/share. The smallest revenue quarter within our data set was Q3 2012 when Pacific Biosciences reported revenue of 0.00B.

On this page we presented the PACB historical earnings date information for Pacific Biosciences. Reviewing that PACB Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2020, when PACB posted adjusted EPS of 0.370/share. Meanwhile the lowest PACB historical earnings result was in Q1 2021, when PACB posted adjusted EPS of -0.450/share. Moving to Pacific Biosciencess historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2015 when PACB reported 36.28M in revenue, while the smallest revenue quarter was Q3 2012 when PACB reported 0.00B in revenue.

For self directed investors doing their due diligence on PACB or any other given stock, their research can benefit from looking into all of the Pacific Biosciences historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Pacific Biosciences historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for PACB. Thanks for visiting, and the next time you need to research PACB historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: TS Price Target, Institutional Holders of BRCD, TLS Average Annual Return.

 

PACB Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.